Lacosamide G.L. Pharma

Lacosamide, the active ingredient in Lacosamide G.L. Pharma, is an anticonvulsant presented as an oral dosage form for oral use. It is indicated for the treatment of partial‑onset seizures and epilepsy in patients who require additional seizure control. It is formulated for convenient oral administration and is used under medical supervision to manage seizure activity.

GNH USA supplies Lacosamide G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Lacosamide is an anticonvulsant used in the management of seizure disorders.

Partial‑onset seizures: reduces the frequency of focal seizure episodes in patients with uncontrolled seizures. Adjunctive therapy in epilepsy: provides additional seizure control when combined with other antiepileptic drugs. Refractory focal epilepsy: improves seizure management in patients not adequately controlled by prior therapies.

Lacosamide may be associated with several adverse reactions, ranging from common to rare but serious events.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac arrhythmias (e.g., PR interval prolongation) - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or behavior

When prescribing lacosamide, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose in patients with reduced kidney function. Hepatic dysfunction: monitor liver enzymes and consider dose adjustment. Cardiac conduction: assess ECG for PR interval prolongation before initiating therapy. Concomitant antiepileptic drugs: evaluate for additive CNS depression. Pregnancy and lactation: use only if potential benefit justifies potential risk; data limited. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lacosamide can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may significantly reduce lacosamide plasma concentrations. - Concomitant use with other sodium channel blockers (e.g., lamotrigine, oxcarbazepine): may increase risk of cardiac conduction abnormalities.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may require INR monitoring. - Alcohol: may enhance CNS depressive effects. - Other antiepileptic drugs: may require dose adjustments based on therapeutic response.